CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NUVL

Neladalkib (NVL-655)

Phase 3
Nuvalent, Inc. (NUVL)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
7d
NUVLPDUFA
Phase 3Positive

FDA PDUFA Date NUV-1034 (standard)

Neladalkib (NVL-655)
Sep 26
SEC
Drug Information

Target Indication

Non-small Cell Lung Cancer

Clinical Trial

NCT06765109

Last updated: 2/13/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.